These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31728550)

  • 1. Identification of novel scaffolds targeting Mycobacterium tuberculosis.
    Dal Molin M; Selchow P; Schäfle D; Tschumi A; Ryckmans T; Laage-Witt S; Sander P
    J Mol Med (Berl); 2019 Nov; 97(11):1601-1613. PubMed ID: 31728550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target.
    Gurcha SS; Usha V; Cox JA; Fütterer K; Abrahams KA; Bhatt A; Alderwick LJ; Reynolds RC; Loman NJ; Nataraj V; Alemparte C; Barros D; Lloyd AJ; Ballell L; Hobrath JV; Besra GS
    PLoS One; 2014; 9(11):e113568. PubMed ID: 25409504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.
    La Rosa V; Poce G; Canseco JO; Buroni S; Pasca MR; Biava M; Raju RM; Porretta GC; Alfonso S; Battilocchio C; Javid B; Sorrentino F; Ioerger TR; Sacchettini JC; Manetti F; Botta M; De Logu A; Rubin EJ; De Rossi E
    Antimicrob Agents Chemother; 2012 Jan; 56(1):324-31. PubMed ID: 22024828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents.
    Singh U; Akhtar S; Mishra A; Sarkar D
    J Microbiol Methods; 2011 Feb; 84(2):202-7. PubMed ID: 21129420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
    Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.
    Guzman JD; Gupta A; Evangelopoulos D; Basavannacharya C; Pabon LC; Plazas EA; Muñoz DR; Delgado WA; Cuca LE; Ribon W; Gibbons S; Bhakta S
    J Antimicrob Chemother; 2010 Oct; 65(10):2101-7. PubMed ID: 20719764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.
    Abrahams KA; Cox JA; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Fernández R; Alemparte C; Remuiñán MJ; Barros D; Ballell L; Besra GS
    PLoS One; 2012; 7(12):e52951. PubMed ID: 23300833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique.
    Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ
    J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
    McNeil MB; O'Malley T; Dennison D; Shelton CD; Sunde B; Parish T
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
    Altaf M; Miller CH; Bellows DS; O'Toole R
    Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter.
    Zheng H; Williams JT; Coulson GB; Haiderer ER; Abramovitch RB
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement Dependent and Independent Interaction Between Bovine Conglutinin and
    Mehmood A; Kouser L; Kaur A; Holmskov U; Al-Ahdal MN; Sim RB; Kishore U; Tsolaki AG
    Front Immunol; 2018; 9():3159. PubMed ID: 30804949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases.
    Nguyen PC; Madani A; Santucci P; Martin BP; Paudel RR; Delattre S; Herrmann JL; Spilling CD; Kremer L; Canaan S; Cavalier JF
    Int J Antimicrob Agents; 2018 Apr; 51(4):651-654. PubMed ID: 29241819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.